On the recordMay 10, 2016
I thank my friend, the ranking member and former chairman of the Judiciary Committee, and, if I could say, in a bipartisan bill, maybe the next chairman of the Judiciary Committee, with all due respect to my friend Mr. Goodlatte. I thank the gentleman very much for bringing this bill to the floor. I thank the majority leader for his comments, and I rise in support, obviously, of this legislation, which I am proud to cosponsor with my friend, the majority leader, Mr. McCarthy, from California. Mr. Speaker, this bill, as he said, will help ensure that future investments in the fight against opioid addiction are allocated in the most effective way possible. We owe that to the American people, and we owe it to the effectiveness of our efforts against this scourge on our country. Our bill requires the Departments of Justice and Health and Human Services to develop, as you have heard, metrics by which opioid-related grant programs will be evaluated: Do they work? Are they worth the investment? It will facilitate data collection and analysis in order to determine best practices--what works and what doesn't--so policymakers can best target resources. The opioid epidemic is a major public health challenge that requires and demands bipartisan cooperation and leadership across the branches and offices of our government at the Federal, State, and local levels.…





